Education
About Us
Working with TipRanks
Follow Us
Cronos Group (TSE:CRON)
TSX:CRON
CRON Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$2.65 - C$4.28
Previous CloseN/A
Volume78.08K
Average Volume (3M)154.27K
Market Cap
$1.04B
Enterprise ValueC$59.24M
Total Cash (Recent Filing)$858.80M
Total Debt (Recent Filing)$2.02M
Price to Earnings (P/E)18.2
Beta1.05
Next Earnings
May 13, 2025EPS Estimate
<0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.15
Shares Outstanding382,530,800
10 Day Avg. Volume184,692
30 Day Avg. Volume154,271
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)6.21
Price to Cash Flow (P/CF)23.70
P/FCF Ratio23.70
Enterprise Value/Market Cap0.06
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.35
Enterprise Value/Ebitda-1.18
Forecast
1Y Price Target
C$3.64Price Target Upside34.67% Upside
Rating ConsensusHold
Number of Analyst Covering3
---
Cronos Group News
PremiumCompany Announcements
Cronos Group Reports Strong 2024 Financial Results
PremiumCompany Announcements
Cronos Group Earnings Call Highlights Growth and ChallengesPremiumCompany Announcements
Cronos Group Achieves Record Growth and Market Leadership in 2024---
Bulls Say, Bears Say
Bulls Say
Financial HealthCronos Group is showing progress in sales growth and cost reduction, which indicates some improvement in the company's financial health.
Sales GrowthGrowth was strong in multiple markets, including a 57% increase in Israel and 183% in other countries.
Bears Say
Regulatory ChallengesRegulatory challenges, including unclear US federal cannabis reform and changes to the Canadian Cannabis Act, are significant factors that negatively impact the stock's valuation.
---
Options Prices
Currently, No data available
---
Ownership Overview
3.41% Insiders
1.80% Mutual Funds
― Other Institutional Investors
90.44% Public Companies and
Individual Investors
CRON FAQ
What was Cronos Group’s price range in the past 12 months?
Cronos Group lowest stock price was C$2.65 and its highest was C$4.28 in the past 12 months.
What is Cronos Group’s market cap?
Cronos Group’s market cap is $1.04B.
When is Cronos Group’s upcoming earnings report date?
Cronos Group’s upcoming earnings report date is May 13, 2025 which is in 60 days.
How were Cronos Group’s earnings last quarter?
Cronos Group released its earnings results on Feb 27, 2025. The company reported C$0.158 earnings per share for the quarter, beating the consensus estimate of C$0 by C$0.158.
Is Cronos Group overvalued?
According to Wall Street analysts Cronos Group’s price is currently Undervalued.
Does Cronos Group pay dividends?
Cronos Group does not currently pay dividends.
What is Cronos Group’s EPS estimate?
Cronos Group’s EPS estimate is <0.01.
How many shares outstanding does Cronos Group have?
Cronos Group has 382,530,800 shares outstanding.
What happened to Cronos Group’s price movement after its last earnings report?
Cronos Group reported an EPS of C$0.158 in its last earnings report, beating expectations of C$0. Following the earnings report the stock price went up 7.925%.
Which hedge fund is a major shareholder of Cronos Group?
Currently, no hedge funds are holding shares in TSE:CRON
---
Cronos Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
C$3.64 (34.67% Upside)
C$3.64 (34.67% Upside)
Blogger Sentiment
Bullish
TSE:CRON Sentiment 83%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Negative
Last 7 Days ▼ 0.6%
Last 30 Days ▼ 1.4%
Last 30 Days ▼ 1.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.06%
12-Months-Change
Fundamentals
Return on Equity
3.80%
Trailing 12-Months
Asset Growth
2.30%
Trailing 12-Months
Company Description
Cronos Group
Cronos Group Inc. is a global cannabinoid company with a focus on advancing cannabis research, technology, and product development. The company operates within the cannabis industry and is involved in the cultivation, manufacturing, and marketing of cannabis and cannabis-derived products. Cronos Group's core products include dried cannabis, cannabis oils, and derivative products that are distributed under various brands for both the medical and recreational markets.
---
CRON Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Cronos Group's earnings call highlighted strong revenue growth, improved margins, and market leadership in Canada, supported by a robust financial position. However, challenges remain, particularly in Israel and a dependency on the GrowCo expansion for future growth. Overall, the sentiment is positive due to the significant achievements and strategic positioning for future opportunities.Read More>---
CRON Stock 12 Month Forecast
Average Price Target
C$3.64
▲(34.67% Upside)
Technical Analysis
Best Analysts Covering CRON
1 Year
1 Year Success Rate
10/14 ratings generated profit
1 Year Average Return
+7.17%
reiterated a sell rating 15 days ago
Copying Lisa Lewandowski's trades and holding each position for 1 Year would result in 71.43% of your transactions generating a profit, with an average return of +7.17% per trade.
---